Benzimidazole derivatives useful as TRPM8 channel modulators

Details for Australian Patent Application No. 2010258713 (hide)

Owner Janssen Pharmaceutica NV

Inventors Macielag, Mark J.; Xia, Mingde; Xu, Xiaoqing

Agent Shelston IP

Pub. Number AU-A-2010258713

PCT Pub. Number WO2010/144679

Priority 61/185,681 10.06.09 US

Filing date 10 June 2010

Wipo publication date 16 December 2010

International Classifications

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61K 31/4184 (2006.01)

A61K 31/4188 (2006.01)

C07D 235/30 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 498/06 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

12 January 2012 PCT application entered the National Phase

  PCT publication WO2010/144679 Priority application(s): WO2010/144679

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258714-Benzimidazole derivatives useful as TRPM8 channel modulators

2010258710-Photoluminescent optical fibers and sights comprising same